Shire boosted by new US drug approval
Pharmaceuticals manufacturer Shire saw its shares rise by 2.16% to 4,518p after its Takhzyro treatment received approval from the United States FDA.
Pharmaceuticals manufacturer Shire saw its shares rise by 2.16% to 4,518p after its Takhzyro treatment received approval from the United States FDA.
AIM-listed technology firm EQTEC has said that it will restructure its Spanish subsidiary to focus on pipeline execution.
Online gambling outfit Playtech earned revenues of €436.5 million for the first half despite tough market conditions in Asia dragging results down.
FTSE 250 hydrocarbon firm Premier Oil produced 76.2 kboepd during the first half, lower than the same period of 2017 due to asset sales and natural decline.
AIM-listed enterprise software provider Sopheon saw its shares climb by 8.40% after the firm’s revenues for the first half grew by 27.2% to $15.9 million.
Builders merchants Grafton grew its revenues for the first half by 9% to £1.44 billion, driven by both organic growth and the acquisition of Leyland SDM.
AIM-listed building products manufacturer Epwin saw its revenues for the first half drop, but beat expectations despite adverse weather conditions.
Virtual reality and music software developer EVR earned its first revenues in the six months ended 30th June, but made a £4.4 million loss for the period.
Persimmon improved its pre-tax profits for the fist half by 13% to £516.3 million as both the number of homes sold and average prices continued to rise.
Shares in John Wood climbed by 6.47% to 704.20p after the company’s revenues for the first half grew by 13% and it posted strong EBITDA.